Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
foreign investment in U.S. real estate has surged to unprecedented levels, surpassing 1.2 trillion dollars over the past 15 years. This influx has sparked a robust debate among scholars and policymakers about the potential threats and benefits posed by such investments.
With the rise of digital interactions, Aflac is tailoring its strategies to engage Gen Z and other demographics, focusing on seamless digital experiences and omnichannel engagement.
U.S. single-family homebuilding sector has hit an eight-month low in June, largely due to escalating mortgage rates. This downturn suggests a potential drag on the nation's economic growth during the second quarter.
The U.S. economy continues to demonstrate its robustness, as evidenced by a notable GDP growth of 2.8% in the second quarter of 2024.
As we navigate this rising tide of risk, the insurance industry must innovate and adapt to ensure that protection remains viable for those who need it most. The stakes have never been higher, and the time for action is now.
With rates now in the low 6% range, a recent 50-basis-point rate cut by the Federal Reserve has sparked optimism among prospective buyers.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
